The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 30-41

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal   Lebrun Fabienne   Awada Ahmad   Piccart Martine J.  

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

By Patel Mital   Vogelbaum Michael A   Barnett Gene H   Jalali Rakesh   Ahluwalia Manmeet S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1247-1266

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions

By  

Current Medicinal Chemistry, Vol. 16, Iss. 7, 2009-03 ,pp. : 780-795

Bentham Science Publishers

Access to resources Recommend Favorite